Safety and Tolerability of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis
Clinical trial NCT01497262 · COMPLETED
Trial details
- NCT number
- NCT01497262
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2014-04-01
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.